Cue Biopharma, Inc. Deposits Assets, Current
Cue Biopharma, Inc. (CUE) had Deposits Assets, Current of $22.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DepositsAssetsCurrent · last filed 2026-08-14
- 2026-06-30: Deposits Assets, Current $22.00K.
- 2026-03-31: Deposits Assets, Current $1.06M.
- 2025-12-31: Deposits Assets, Current $1.09M.
- 2025-09-30: Deposits Assets, Current $1.75M.
| Period end | Deposits Assets, Current | Deposits Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $22.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.06M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $1.09M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $1.75M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $470.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $912.00K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $929.00K 10-K · filed 2026-03-16 | |
| 2023-12-31 | $287.00K 10-K · filed 2025-03-31 | |
| 2018-03-31 | $510.00K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $225.50K 10-K · filed 2019-03-14 | $226.00K 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |